MSB 1.79% $1.42 mesoblast limited

biotechs and big pharmas on lookout

  1. 384 Posts.
    lightbulb Created with Sketch. 5
    Hi Guys,

    A good read for any Biotech investor.

    Looks like Big Pharmas will have some competition from junior Pharmas in a race to beef up their respective pipelines against upcoming patent cliffs.

    Good on TEVA(CEPH) in being on the front foot with 19.99% stake in Mesoblast.One thing for certain - music to the ears of CEO Itescu and stakeholders.
    The above is IMO only, so please dyor.

    http://www.bloomberg.com/news/2012-01-06/amgen-may-join-gilead-as-biotechs-seek-acquisitions-to-grow.html,

    ALSO (seperate to the presenation at the Alliance for RM Tuesday 10/1/12) MSB is also presenting at The 30th Annual JPMorgan Chase Healthcare Conference, Jan-11-2012 10:30 AM

    http://investing.businessweek.com/research/stocks/snapshot/snapshot.asp?ticker=MSB:AU.

    Good luck to all holders.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.42
Change
0.025(1.79%)
Mkt cap ! $1.621B
Open High Low Value Volume
$1.41 $1.43 $1.40 $1.286M 912.4K

Buyers (Bids)

No. Vol. Price($)
4 10878 $1.42
 

Sellers (Offers)

Price($) Vol. No.
$1.43 287437 7
View Market Depth
Last trade - 10.46am 11/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.